News Column

New Stem Cells Data Have Been Reported by Researchers at National Yang Ming University

May 28, 2014



By a News Reporter-Staff News Editor at Biotech Week -- Researchers detail new data in Stem Cell Research. According to news reporting from Taipei, Taiwan, by NewsRx journalists, research stated, "In recent decades, nanotechnology has attracted major interests in view of drug delivery systems and therapies against diseases, such as cancer, neurodegenerative diseases, and many others. Nanotechnology provides the opportunity for nanoscale particles or molecules (so called 'Nanomedicine') to be delivered to the targeted sites, thereby, reducing toxicity (or side effects) and improving drug bioavailability."

The news correspondents obtained a quote from the research from National Yang Ming University, "Nowadays, a great deal of nano-structured particles/vehicles has been discovered, including polymeric nanoparticles, lipid-based nanoparticles, and mesoporous silica nanoparticles. Nanomedical utilizations have already been well developed in many different aspects, including disease treatment, diagnostic, medical devices designing, and visualization (i.e., cell trafficking). However, while quite a few successful progressions on chemotherapy using nanotechnology have been developed, the implementations of nanoparticles on stem cell research are still sparsely populated. Stem cell applications and therapies are being considered to offer an outstanding potential in the treatment for numbers of maladies. Human induced pluripotent stem cells (iPSCs) are adult cells that have been genetically reprogrammed to an embryonic stem cell-like state. Although the exact mechanisms underlying are still unclear, iPSCs are already being considered as useful tools for drug development/screening and modeling of diseases. Recently, personalized medicines have drawn great attentions in biological and pharmaceutical studies. Generally speaking, personalized medicine is a therapeutic model that offers a customized healthcare/cure being tailored to a specific patient based on his own genetic information. Consequently, the combination of nanomedicine and iPSCs could actually be the potent arms for remedies in transplantation medicine and personalized medicine."

According to the news reporters, the research concluded: "This review will focus on current use of nanoparticles on therapeutical applications, nanomedicine-based neuroprotective manipulations in patient specific-iPSCs and personalized medicine."

For more information on this research see: Nanomedicine-based neuroprotective strategies in patient specific-iPSC and personalized medicine. International Journal of Molecular Sciences, 2014;15(3):3904-25 (see also Stem Cell Research).

Our news journalists report that additional information may be obtained by contacting S.F. Jang, School of Medicine, National Yang-Ming University, No 155, Sec 2, Linong Street, Taipei 11221, Taiwan. Additional authors for this research include W.H. Liu, W.S. Song, K.L. Chiang, H.I. Ma, C.L. Kao and M.T Chen.

Keywords for this news article include: Asia, Drugs, Taipei, Taiwan, Chemotherapy, Nanoparticle, Therapeutics, Nanotechnology, Stem Cell Research, Emerging Technologies, Personalized Medicine.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Biotech Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters